Seoul, South Korea

Chang-Wan Joo


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: **Innovator Spotlight: Chang-Wan Joo from Seoul, KR**

Introduction

Chang-Wan Joo is a notable inventor based in Seoul, South Korea, recognized for his contribution to the biotechnology sector. With a keen focus on adenoviral technology, he has developed innovative solutions that enhance gene therapy applications.

Latest Patents

Chang-Wan Joo holds a patent for an invention titled "Adenovirus producing novel cell line and the use thereof." This groundbreaking patent pertains to a specially engineered cell line that incorporates an expression construct into its genomic DNA. The construct features a promoter that operates in animal cells, distinct from adenoviruses, and includes a modified adenovirus El coding gene sequence. This novel cell line has demonstrated a significantly reduced likelihood of producing a replication competent adenovirus (RCA), which is crucial for minimizing risks during gene therapy. The innovation aims to control the amount of adenovirus produced, mitigating potential tissue damage and toxic effects associated with overproduction.

Career Highlights

As part of his professional journey, Chang-Wan Joo is affiliated with Viromed Co., Ltd., an organization at the forefront of biotechnology research. His career is marked by a dedication to advancing health solutions through innovative research and development, particularly in the realm of gene therapy.

Collaborations

At Viromed Co., Ltd., Chang-Wan collaborates with fellow specialists, including Seung Shin Yu and Jin-A Chae. These partnerships are vital to enhancing his research efforts and driving forward the objectives of their projects, specifically in improving viral production technologies.

Conclusion

Chang-Wan Joo's contributions to the field of biotechnology through his patent for an adenovirus-producing cell line underscore the importance of innovation in gene therapy. His work not only showcases the advancements in adenoviral technology but also emphasizes the collaborative spirit essential for scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…